Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01288105 · ClinicalTrials.gov registry record · Phase 4
Use of Optical Coherence Tomography to Determine the Optimal Management of Patients With Drug-eluting Stents Who Need Non-cardiac Surgery
A Phase 4 study, sponsored by North Texas Veterans Healthcare System.
- Terminated
- Registry status
- Phase 4
- Development phase
- 107
- Enrollment target
NCT01288105 is a Phase 4 study that was terminated before completion, run by North Texas Veterans Healthcare System. The registered enrollment target is 107 participants.
The verdict
NCT01288105, a Phase 4 study, was terminated before completion, sponsored by North Texas Veterans Healthcare System.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 107 participants
- Enrollment target
Study Summary
The specific aim of this proposal is to examine the impact of OCT and IVUS-guided management of patients with prior DES implantation who need major non-cardiac surgery and discontinuation of dual antiplatelet therapy on the perioperative (1 week prior to surgery until 30 days post surgery) incidence of major adverse cardiac events.
Interventions
- DEVICE Optical coherence tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01288105
The ClinicalTrials.gov registry entry for NCT01288105 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is North Texas Veterans Healthcare System, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Optical coherence tomography is the first listed.
NCT01288105 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01288105 about?
NCT01288105 is a clinical study titled "Use of Optical Coherence Tomography to Determine the Optimal Management of Patients With Drug-eluting Stents Who Need Non-cardiac Surgery". The specific aim of this proposal is to examine the impact of OCT and IVUS-guided management of patients with prior DES implantation who need major non-cardiac surgery and discontinuation of dual antiplatelet therapy on the perioperative (1 week prior to surgery until 30 days post surgery) incidence...
What is the current status of trial NCT01288105?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 107 participants. The study started on 2011-01. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01288105?
The interventions under investigation include: Optical coherence tomography (DEVICE).
Who is sponsoring clinical trial NCT01288105?
This trial is sponsored by North Texas Veterans Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.